11:54 AM EST - Amorfix Life Sciences : announced its operational and financial results for the third quarter ended December 31, 2011. The net loss for the three months ended December 31, 2011 was $731,287 compared to a net loss of $810,029 for the three months ended December 31, 2010. For the three months ended December 31, 2011 revenue from services and sales was $18,554, as compared to $10,048 in the comparative periods. Amorfix Life Sciences
shares T.AMF are trading down $0.025 at $0.25.
